Identity and percentage holding of significant shareholders
|Substantial holdings||Shares held||%|
|Global Health Investment Fund I, LLC||2,700,000||4.27%*|
|Spreadex Ltd||2,123,478||3.77%* **|
|Directors and related shareholders|
|Total Directors' holdings||1,339,862||1.46%|
|Total shares in issue||91,770,900||100.00%|
* - DATE OF LAST NOTIFICATION
** - Note 494,425 of these shares are held via a CFD/Spreadbet
genedrive shares are quoted and traded on the AIM market of the London Stock Exchange.
Authorised Share Capital: No authorised maximum number of shares are required. There are no shares held in treasury and there are no restrictions on transfer.
Issued Share Capital: The total number of genedrive plc ordinary shares of 1.5p each in issue is 91,770,900.
Number of AIM securities not in public hands is 1,339,862 or 1.46%.
Text updated: 1/10/2021
30 March 2021
Interim Report and Accounts 31 December 2020
Tuesday August 31, 2021
Thursday July 01, 2021
Wednesday February 03, 2021